Literature DB >> 23823983

Integrated pathways of parkin control over mitochondrial maintenance - relevance to Parkinson's disease pathogenesis.

Katarzyna Gaweda-Walerych1, Cezary Zekanowski.   

Abstract

Mitochondrial dysfunction and oxidative stress are considered among the main molecular mechanisms implicated in Parkinson's disease (PD) pathogenesis. Here, we focus on the deficiency of PARK2 and its product parkin, which is relevant to both familial and sporadic PD pathogenesis. Parkin emerges as an important regulator of processes that maintain mitochondrial quality. We focus on the parkin-dependent aspects of mitochondrial biogenesis, including mtDNA replication, transcription, mitophagy, mitochondrial fusion, fission, and transport. We discuss possible underlying molecular mechanisms, exerted by parkin in cooperation with other mitochondrial maintenance factors such as TFAM, PGC-1alpha, mortalin, HSP70/HSC70 and LRPPRC, all of them implicated in PD pathogenesis. We review numerous models of lipopolysaccharide toxicity that demonstrate how mitochondrial biogenesis and mitophagy are induced simultaneously to cope with mitochondrial dysfunction. The spatial and temporal interdependence of mitochondrial quality pathways underscores the importance of an integrative approach for future studies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23823983

Source DB:  PubMed          Journal:  Acta Neurobiol Exp (Wars)        ISSN: 0065-1400            Impact factor:   1.579


  11 in total

1.  Stress chaperone mortalin regulates human melanogenesis.

Authors:  Renu Wadhwa; Didik Priyandoko; Ran Gao; Nashi Widodo; Nupur Nigam; Ling Li; Hyo Min Ahn; Chae-Ok Yun; Nobuhiro Ando; Christian Mahe; Sunil C Kaul
Journal:  Cell Stress Chaperones       Date:  2016-04-07       Impact factor: 3.667

2.  Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.

Authors:  Milena Pinto; Nadee Nissanka; Carlos T Moraes
Journal:  J Neurosci       Date:  2017-12-08       Impact factor: 6.167

3.  Folic Acid Supplementation Ameliorates Oxidative Stress, Metabolic Functions and Developmental Anomalies in a Novel Fly Model of Parkinson's Disease.

Authors:  Saurabh Srivastav; Sandeep Kumar Singh; Amarish Kumar Yadav; Saripella Srikrishna
Journal:  Neurochem Res       Date:  2015-05-12       Impact factor: 3.996

Review 4.  Regulation of mitochondrial biogenesis and its intersection with inflammatory responses.

Authors:  Anne D Cherry; Claude A Piantadosi
Journal:  Antioxid Redox Signal       Date:  2015-02-11       Impact factor: 8.401

5.  Association of mitochondrial DNA levels with frailty and all-cause mortality.

Authors:  Foram N Ashar; Anna Moes; Ann Z Moore; Megan L Grove; Paulo H M Chaves; Josef Coresh; Anne B Newman; Amy M Matteini; Karen Bandeen-Roche; Eric Boerwinkle; Jeremy D Walston; Dan E Arking
Journal:  J Mol Med (Berl)       Date:  2014-12-04       Impact factor: 4.599

6.  Parkin Levels Decrease in Fibroblasts With Progranulin (PGRN) Pathogenic Variants and in a Cellular Model of PGRN Deficiency.

Authors:  Katarzyna Gaweda-Walerych; Dawid Walerych; Mariusz Berdyński; Emanuele Buratti; Cezary Zekanowski
Journal:  Front Mol Neurosci       Date:  2021-05-13       Impact factor: 5.639

7.  Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits.

Authors:  Shinichi Amano; Deborah Kegelmeyer; S Lee Hong
Journal:  Front Syst Neurosci       Date:  2015-01-06

Review 8.  Neuroprotection through flavonoid: Enhancement of the glyoxalase pathway.

Authors:  Joel R Frandsen; Prabagaran Narayanasamy
Journal:  Redox Biol       Date:  2017-10-18       Impact factor: 11.799

9.  LRPPRC: A Multifunctional Protein Involved in Energy Metabolism and Human Disease.

Authors:  Jie Cui; Li Wang; Xiaoyue Ren; Yamin Zhang; Hongyi Zhang
Journal:  Front Physiol       Date:  2019-05-24       Impact factor: 4.566

10.  The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.

Authors:  Katarzyna Gaweda-Walerych; Cezary Zekanowski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.